ArticleCureus2025
The Use of Testicular Sperm Extraction in Male Infertility Patients Without Azoospermia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Testicular sperm extraction (TESE) in its various versions has been traditionally used in male infertility patients with azoospermia, with the intention of utilizing surgically retrieved sperm for in vitro fertilization (IVF) with or without intra-cytoplasmic sperm injection (ICSI). Possible risks of TESE include bleeding, infection, and inability to find sperm. Microdissection TESE, a more extensive type of surgical sperm retrieval procedure, may be associated with a transient post-operative decline in serum testosterone levels. More recently, the possibility of using TESE in non-azoospermic infertile men has been gaining attention. However, heterogeneity still exists in the available data. Older studies reported limited clinical benefits for the utilization of testicular over ejaculated spermatozoa, while newer publications suggest more promising outcomes for the utilization of surgically retrieved sperm for ICSI in non-azoospermic patients. Suggested indications for TESE in non-azoospermic infertile men included failure of IVF cycles utilizing ejaculated sperm, high sperm DNA fragmentation index, cryptozoospermia, and necrospermia. This editorial provides insight into the rationale, potential candidates and benefits for the consideration of TESE in non-azoospermic infertile men.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.